ID   BRD4_HUMAN              Reviewed;         722 AA.
AC   O60885-2;
DT   11-JAN-2001, integrated into UniProtKB/Swiss-Prot.
DT   31-JAN-2002, sequence version 2.
DT   12-OCT-2022, entry version 204.
DE   RecName: Full=Isoform C of Bromodomain-containing protein 4;
DE   AltName: Full=Protein HUNK1;
GN   Name=BRD4; Synonyms=HUNK1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM A), DISEASE, AND CHROMOSOMAL
RP   TRANSLOCATION WITH NUT.
RX   PubMed=11733348; DOI=10.1016/s0002-9440(10)63049-0;
RA   French C.A., Miyoshi I., Aster J.C., Kubonishi I., Kroll T.G., Dal Cin P.,
RA   Vargas S.O., Perez-Atayde A.R., Fletcher J.A.;
RT   "BRD4 bromodomain gene rearrangement in aggressive carcinoma with
RT   translocation t(15;19).";
RL   Am. J. Pathol. 159:1987-1992(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM C).
RC   TISSUE=Placenta;
RA   Weber B.;
RL   Submitted (MAR-1997) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J., Lamerdin J.E.,
RA   Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M., Aerts A.,
RA   Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E., Caenepeel S.,
RA   Carrano A.V., Caoile C., Chan Y.M., Christensen M., Cleland C.A.,
RA   Copeland A., Dalin E., Dehal P., Denys M., Detter J.C., Escobar J.,
RA   Flowers D., Fotopulos D., Garcia C., Georgescu A.M., Glavina T., Gomez M.,
RA   Gonzales E., Groza M., Hammon N., Hawkins T., Haydu L., Ho I., Huang W.,
RA   Israni S., Jett J., Kadner K., Kimball H., Kobayashi A., Larionov V.,
RA   Leem S.-H., Lopez F., Lou Y., Lowry S., Malfatti S., Martinez D.,
RA   McCready P.M., Medina C., Morgan J., Nelson K., Nolan M., Ovcharenko I.,
RA   Pitluck S., Pollard M., Popkie A.P., Predki P., Quan G., Ramirez L.,
RA   Rash S., Retterer J., Rodriguez A., Rogers S., Salamov A., Salazar A.,
RA   She X., Smith D., Slezak T., Solovyev V., Thayer N., Tice H., Tsai M.,
RA   Ustaszewska A., Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J.,
RA   Dubchak I., Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM B).
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-719, DISEASE, CHROMOSOMAL TRANSLOCATION
RP   WITH NUT, AND TISSUE SPECIFICITY.
RC   TISSUE=Carcinoma;
RX   PubMed=12543779;
RA   French C.A., Miyoshi I., Kubonishi I., Grier H.E., Perez-Atayde A.R.,
RA   Fletcher J.A.;
RT   "BRD4-NUT fusion oncogene: a novel mechanism in aggressive carcinoma.";
RL   Cancer Res. 63:304-307(2003).
RN   [7]
RP   FUNCTION, INTERACTION WITH CDK9 AND CCNT1, IDENTIFICATION IN THE P-TEFB
RP   COMPLEX, AND SUBCELLULAR LOCATION.
RX   PubMed=16109376; DOI=10.1016/j.molcel.2005.06.027;
RA   Jang M.K., Mochizuki K., Zhou M., Jeong H.S., Brady J.N., Ozato K.;
RT   "The bromodomain protein Brd4 is a positive regulatory component of P-TEFb
RT   and stimulates RNA polymerase II-dependent transcription.";
RL   Mol. Cell 19:523-534(2005).
RN   [8]
RP   FUNCTION, INTERACTION WITH CDK9 AND CCNT1, AND IDENTIFICATION IN THE P-TEFB
RP   COMPLEX.
RX   PubMed=16109377; DOI=10.1016/j.molcel.2005.06.029;
RA   Yang Z., Yik J.H., Chen R., He N., Jang M.K., Ozato K., Zhou Q.;
RT   "Recruitment of P-TEFb for stimulation of transcriptional elongation by the
RT   bromodomain protein Brd4.";
RL   Mol. Cell 19:535-545(2005).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1117, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [10]
RP   INTERACTION WITH KSHV PROTEIN LANA (MICROBIAL INFECTION).
RX   PubMed=16940503; DOI=10.1128/jvi.00502-06;
RA   You J., Srinivasan V., Denis G.V., Harrington W.J. Jr., Ballestas M.E.,
RA   Kaye K.M., Howley P.M.;
RT   "Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen
RT   interacts with bromodomain protein Brd4 on host mitotic chromosomes.";
RL   J. Virol. 80:8909-8919(2006).
RN   [11]
RP   INTERACTION WITH BOVINE PAPILLOMAVIRUS TYPE 1 REGULATORY PROTEIN E2.
RX   PubMed=17189189; DOI=10.1016/j.molcel.2006.11.005;
RA   Parish J.L., Bean A.M., Park R.B., Androphy E.J.;
RT   "ChlR1 is required for loading papillomavirus E2 onto mitotic chromosomes
RT   and viral genome maintenance.";
RL   Mol. Cell 24:867-876(2006).
RN   [12]
RP   INTERACTION WITH EPSTEIN-BARR VIRUS PROTEIN EBNA1.
RX   PubMed=18922874; DOI=10.1128/jvi.01680-08;
RA   Lin A., Wang S., Nguyen T., Shire K., Frappier L.;
RT   "The EBNA1 protein of Epstein-Barr virus functionally interacts with
RT   Brd4.";
RL   J. Virol. 82:12009-12019(2008).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-470, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [15]
RP   FUNCTION.
RX   PubMed=19596240; DOI=10.1016/j.cell.2009.05.047;
RA   Hargreaves D.C., Horng T., Medzhitov R.;
RT   "Control of inducible gene expression by signal-dependent transcriptional
RT   elongation.";
RL   Cell 138:129-145(2009).
RN   [16]
RP   FUNCTION, AND INTERACTION WITH RELA.
RX   PubMed=19103749; DOI=10.1128/mcb.01365-08;
RA   Huang B., Yang X.D., Zhou M.M., Ozato K., Chen L.F.;
RT   "Brd4 coactivates transcriptional activation of NF-kappaB via specific
RT   binding to acetylated RelA.";
RL   Mol. Cell. Biol. 29:1375-1387(2009).
RN   [17]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-1111, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-601 AND SER-1117, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [19]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [20]
RP   INTERACTION WITH NSD3; JMJD6; CHD4; BICRA AND ATAD5.
RX   PubMed=21555454; DOI=10.1128/mcb.01341-10;
RA   Rahman S., Sowa M.E., Ottinger M., Smith J.A., Shi Y., Harper J.W.,
RA   Howley P.M.;
RT   "The Brd4 extraterminal domain confers transcription activation independent
RT   of pTEFb by recruiting multiple proteins, including NSD3.";
RL   Mol. Cell. Biol. 31:2641-2652(2011).
RN   [21]
RP   SUBCELLULAR LOCATION.
RX   PubMed=21890894; DOI=10.1093/nar/gkr698;
RA   Ai N., Hu X., Ding F., Yu B., Wang H., Lu X., Zhang K., Li Y., Han A.,
RA   Lin W., Liu R., Chen R.;
RT   "Signal-induced Brd4 release from chromatin is essential for its role
RT   transition from chromatin targeting to transcriptional regulation.";
RL   Nucleic Acids Res. 39:9592-9604(2011).
RN   [22]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-601 AND SER-1117, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [23]
RP   FUNCTION.
RX   PubMed=22334664; DOI=10.1074/jbc.m111.323493;
RA   Wang R., Li Q., Helfer C.M., Jiao J., You J.;
RT   "Bromodomain protein Brd4 associated with acetylated chromatin is important
RT   for maintenance of higher-order chromatin structure.";
RL   J. Biol. Chem. 287:10738-10752(2012).
RN   [24]
RP   FUNCTION.
RX   PubMed=23086925; DOI=10.1074/jbc.m112.413047;
RA   Zhang W., Prakash C., Sum C., Gong Y., Li Y., Kwok J.J., Thiessen N.,
RA   Pettersson S., Jones S.J., Knapp S., Yang H., Chin K.C.;
RT   "Bromodomain-containing protein 4 (BRD4) regulates RNA polymerase II serine
RT   2 phosphorylation in human CD4+ T cells.";
RL   J. Biol. Chem. 287:43137-43155(2012).
RN   [25]
RP   FUNCTION.
RX   PubMed=22509028; DOI=10.1073/pnas.1120422109;
RA   Devaiah B.N., Lewis B.A., Cherman N., Hewitt M.C., Albrecht B.K.,
RA   Robey P.G., Ozato K., Sims R.J. III, Singer D.S.;
RT   "BRD4 is an atypical kinase that phosphorylates serine2 of the RNA
RT   polymerase II carboxy-terminal domain.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:6927-6932(2012).
RN   [26]
RP   FUNCTION, AND INTERACTION WITH JMJD6; CDK9 AND CCNT1.
RX   PubMed=24360279; DOI=10.1016/j.cell.2013.10.056;
RA   Liu W., Ma Q., Wong K., Li W., Ohgi K., Zhang J., Aggarwal A.,
RA   Rosenfeld M.G.;
RT   "Brd4 and JMJD6-associated anti-pause enhancers in regulation of
RT   transcriptional pause release.";
RL   Cell 155:1581-1595(2013).
RN   [27]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-601; SER-1126; SER-1201 AND
RP   SER-1204, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [28]
RP   FUNCTION, INTERACTION WITH TP53, PHOSPHORYLATION AT SER-484; SER-488;
RP   SER-492; SER-494; SER-498; SER-499 AND SER-503, AND MUTAGENESIS OF
RP   492-SER--SER-494; 498-SER--THR-500 AND SER-503.
RX   PubMed=23317504; DOI=10.1016/j.molcel.2012.12.006;
RA   Wu S.Y., Lee A.Y., Lai H.T., Zhang H., Chiang C.M.;
RT   "Phospho switch triggers Brd4 chromatin binding and activator recruitment
RT   for gene-specific targeting.";
RL   Mol. Cell 49:843-857(2013).
RN   [29]
RP   FUNCTION.
RX   PubMed=23589332; DOI=10.1128/mcb.01180-12;
RA   Patel M.C., Debrosse M., Smith M., Dey A., Huynh W., Sarai N.,
RA   Heightman T.D., Tamura T., Ozato K.;
RT   "BRD4 coordinates recruitment of pause release factor P-TEFb and the
RT   pausing complex NELF/DSIF to regulate transcription elongation of
RT   interferon-stimulated genes.";
RL   Mol. Cell. Biol. 33:2497-2507(2013).
RN   [30]
RP   FUNCTION (ISOFORM B), SUBCELLULAR LOCATION (ISOFORM B), INTERACTION WITH
RP   NCAPD3 AND SMC2, AND MUTAGENESIS OF ASN-140.
RX   PubMed=23728299; DOI=10.1038/nature12147;
RA   Floyd S.R., Pacold M.E., Huang Q., Clarke S.M., Lam F.C., Cannell I.G.,
RA   Bryson B.D., Rameseder J., Lee M.J., Blake E.J., Fydrych A., Ho R.,
RA   Greenberger B.A., Chen G.C., Maffa A., Del Rosario A.M., Root D.E.,
RA   Carpenter A.E., Hahn W.C., Sabatini D.M., Chen C.C., White F.M.,
RA   Bradner J.E., Yaffe M.B.;
RT   "The bromodomain protein Brd4 insulates chromatin from DNA damage
RT   signalling.";
RL   Nature 498:246-250(2013).
RN   [31]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-470 AND SER-1117, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [32]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-694 AND LYS-1111, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25218447; DOI=10.1038/nsmb.2890;
RA   Hendriks I.A., D'Souza R.C., Yang B., Verlaan-de Vries M., Mann M.,
RA   Vertegaal A.C.;
RT   "Uncovering global SUMOylation signaling networks in a site-specific
RT   manner.";
RL   Nat. Struct. Mol. Biol. 21:927-936(2014).
RN   [33]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-1111, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25114211; DOI=10.1073/pnas.1413825111;
RA   Impens F., Radoshevich L., Cossart P., Ribet D.;
RT   "Mapping of SUMO sites and analysis of SUMOylation changes induced by
RT   external stimuli.";
RL   Proc. Natl. Acad. Sci. U.S.A. 111:12432-12437(2014).
RN   [34]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-1111, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25772364; DOI=10.1016/j.celrep.2015.02.033;
RA   Hendriks I.A., Treffers L.W., Verlaan-de Vries M., Olsen J.V.,
RA   Vertegaal A.C.;
RT   "SUMO-2 orchestrates chromatin modifiers in response to DNA damage.";
RL   Cell Rep. 10:1778-1791(2015).
RN   [35]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-1111, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25755297; DOI=10.1074/mcp.o114.044792;
RA   Xiao Z., Chang J.G., Hendriks I.A., Sigurdsson J.O., Olsen J.V.,
RA   Vertegaal A.C.;
RT   "System-wide analysis of SUMOylation dynamics in response to replication
RT   stress reveals novel small ubiquitin-like modified target proteins and
RT   acceptor lysines relevant for genome stability.";
RL   Mol. Cell. Proteomics 14:1419-1434(2015).
RN   [36]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-99; LYS-585; LYS-645; LYS-694;
RP   LYS-1050; LYS-1111 AND LYS-1197, AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-modification
RT   with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
RN   [37]
RP   INTERACTION WITH BICRA.
RX   PubMed=29374058; DOI=10.1074/jbc.ra117.001065;
RA   Alpsoy A., Dykhuizen E.C.;
RT   "Glioma tumor suppressor candidate region gene 1 (GLTSCR1) and its paralog
RT   GLTSCR1-like form SWI/SNF chromatin remodeling subcomplexes.";
RL   J. Biol. Chem. 293:3892-3903(2018).
RN   [38]
RP   VARIANTS [LARGE SCALE ANALYSIS] SER-37; GLY-371; ASN-563; SER-598 AND
RP   HIS-669.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G.,
RA   Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S.,
RA   Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G.,
RA   Choudhury B., Clements J., Cole J., Dicks E., Forbes S., Gray K.,
RA   Halliday K., Harrison R., Hills K., Hinton J., Jenkinson A., Jones D.,
RA   Menzies A., Mironenko T., Perry J., Raine K., Richardson D., Shepherd R.,
RA   Small A., Tofts C., Varian J., Webb T., West S., Widaa S., Yates A.,
RA   Cahill D.P., Louis D.N., Goldstraw P., Nicholson A.G., Brasseur F.,
RA   Looijenga L., Weber B.L., Chiew Y.-E., DeFazio A., Greaves M.F.,
RA   Green A.R., Campbell P., Birney E., Easton D.F., Chenevix-Trench G.,
RA   Tan M.-H., Khoo S.K., Teh B.T., Yuen S.T., Leung S.Y., Wooster R.,
RA   Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
RN   [39]
RP   STRUCTURE BY NMR OF 352-457.
RX   PubMed=18500820; DOI=10.1021/bi8001659;
RA   Liu Y., Wang X., Zhang J., Huang H., Ding B., Wu J., Shi Y.;
RT   "Structural basis and binding properties of the second bromodomain of Brd4
RT   with acetylated histone tails.";
RL   Biochemistry 47:6403-6417(2008).
RN   [40]
RP   X-RAY CRYSTALLOGRAPHY (1.6 ANGSTROMS) OF 44-168 IN COMPLEX WITH JQ1
RP   INHIBITOR, AND SUBCELLULAR LOCATION.
RX   PubMed=20871596; DOI=10.1038/nature09504;
RA   Filippakopoulos P., Qi J., Picaud S., Shen Y., Smith W.B., Fedorov O.,
RA   Morse E.M., Keates T., Hickman T.T., Felletar I., Philpott M., Munro S.,
RA   McKeown M.R., Wang Y., Christie A.L., West N., Cameron M.J., Schwartz B.,
RA   Heightman T.D., La Thangue N., French C.A., Wiest O., Kung A.L., Knapp S.,
RA   Bradner J.E.;
RT   "Selective inhibition of BET bromodomains.";
RL   Nature 468:1067-1073(2010).
RN   [41]
RP   X-RAY CRYSTALLOGRAPHY (1.6 ANGSTROMS) OF 44-168 IN COMPLEX WITH I-BET
RP   INHIBITOR.
RX   PubMed=21068722; DOI=10.1038/nature09589;
RA   Nicodeme E., Jeffrey K.L., Schaefer U., Beinke S., Dewell S., Chung C.W.,
RA   Chandwani R., Marazzi I., Wilson P., Coste H., White J., Kirilovsky J.,
RA   Rice C.M., Lora J.M., Prinjha R.K., Lee K., Tarakhovsky A.;
RT   "Suppression of inflammation by a synthetic histone mimic.";
RL   Nature 468:1119-1123(2010).
RN   [42]
RP   X-RAY CRYSTALLOGRAPHY (1.65 ANGSTROMS) OF 44-168, AND X-RAY CRYSTALLOGRAPHY
RP   (2.3 ANGSTROMS) OF 333-460.
RX   PubMed=21568322; DOI=10.1021/jm200108t;
RA   Chung C.W., Coste H., White J.H., Mirguet O., Wilde J., Gosmini R.L.,
RA   Delves C., Magny S.M., Woodward R., Hughes S.A., Boursier E.V., Flynn H.,
RA   Bouillot A.M., Bamborough P., Brusq J.M., Gellibert F.J., Jones E.J.,
RA   Riou A.M., Homes P., Martin S.L., Uings I.J., Toum J., Clement C.A.,
RA   Boullay A.B., Grimley R.L., Blandel F.M., Prinjha R.K., Lee K.,
RA   Kirilovsky J., Nicodeme E.;
RT   "Discovery and characterization of small molecule inhibitors of the BET
RT   family bromodomains.";
RL   J. Med. Chem. 54:3827-3838(2011).
RN   [43]
RP   X-RAY CRYSTALLOGRAPHY (1.5 ANGSTROMS) OF 44-168 IN COMPLEX WITH JQ1
RP   INHIBITOR.
RX   PubMed=21964340; DOI=10.1038/nature10509;
RA   Dawson M.A., Prinjha R.K., Dittmann A., Giotopoulos G., Bantscheff M.,
RA   Chan W.I., Robson S.C., Chung C.W., Hopf C., Savitski M.M., Huthmacher C.,
RA   Gudgin E., Lugo D., Beinke S., Chapman T.D., Roberts E.J., Soden P.E.,
RA   Auger K.R., Mirguet O., Doehner K., Delwel R., Burnett A.K., Jeffrey P.,
RA   Drewes G., Lee K., Huntly B.J., Kouzarides T.;
RT   "Inhibition of BET recruitment to chromatin as an effective treatment for
RT   MLL-fusion leukaemia.";
RL   Nature 478:529-533(2011).
RN   [44]
RP   X-RAY CRYSTALLOGRAPHY (1.6 ANGSTROMS) OF 44-168 IN COMPLEX WITH
RP   BENZODIAZEPINES AND BENZOTRIAZEPINES INHIBITORS.
RX   PubMed=22137933; DOI=10.1016/j.bmc.2011.10.080;
RA   Filippakopoulos P., Picaud S., Fedorov O., Keller M., Wrobel M.,
RA   Morgenstern O., Bracher F., Knapp S.;
RT   "Benzodiazepines and benzotriazepines as protein interaction inhibitors
RT   targeting bromodomains of the BET family.";
RL   Bioorg. Med. Chem. 20:1878-1886(2012).
RN   [45]
RP   X-RAY CRYSTALLOGRAPHY (1.4 ANGSTROMS) OF 44-168, AND STRUCTURE BY NMR OF
RP   333-460.
RX   PubMed=22645123; DOI=10.1074/jbc.m112.359505;
RA   Zhang G., Liu R., Zhong Y., Plotnikov A.N., Zhang W., Zeng L., Rusinova E.,
RA   Gerona-Nevarro G., Moshkina N., Joshua J., Chuang P.Y., Ohlmeyer M.,
RA   He J.C., Zhou M.M.;
RT   "Down-regulation of NF-kappaB transcriptional activity in HIV-associated
RT   kidney disease by BRD4 inhibition.";
RL   J. Biol. Chem. 287:28840-28851(2012).
RN   [46]
RP   X-RAY CRYSTALLOGRAPHY (1.6 ANGSTROMS) OF 44-168 IN COMPLEX WITH
RP   BENZODIAZEPINES INHIBITORS.
RX   PubMed=22136404; DOI=10.1021/jm201320w;
RA   Chung C.W., Dean A.W., Woolven J.M., Bamborough P.;
RT   "Fragment-based discovery of bromodomain inhibitors part 1: inhibitor
RT   binding modes and implications for lead discovery.";
RL   J. Med. Chem. 55:576-586(2012).
RN   [47]
RP   X-RAY CRYSTALLOGRAPHY (1.92 ANGSTROMS) OF 44-168.
RX   PubMed=23095041; DOI=10.1021/jm3010515;
RA   Fish P.V., Filippakopoulos P., Bish G., Brennan P.E., Bunnage M.E.,
RA   Cook A.S., Federov O., Gerstenberger B.S., Jones H., Knapp S., Marsden B.,
RA   Nocka K., Owen D.R., Philpott M., Picaud S., Primiano M.J., Ralph M.J.,
RA   Sciammetta N., Trzupek J.D.;
RT   "Identification of a chemical probe for bromo and extra C-terminal
RT   bromodomain inhibition through optimization of a fragment-derived hit.";
RL   J. Med. Chem. 55:9831-9837(2012).
RN   [48]
RP   X-RAY CRYSTALLOGRAPHY (1.35 ANGSTROMS) OF 44-168; 333-460 AND 1343-1362 IN
RP   COMPLEX WITH ACETYLATED HISTONE, AND MUTAGENESIS OF ASN-140 AND ASN-433.
RX   PubMed=22464331; DOI=10.1016/j.cell.2012.02.013;
RA   Filippakopoulos P., Picaud S., Mangos M., Keates T., Lambert J.P.,
RA   Barsyte-Lovejoy D., Felletar I., Volkmer R., Muller S., Pawson T.,
RA   Gingras A.C., Arrowsmith C.H., Knapp S.;
RT   "Histone recognition and large-scale structural analysis of the human
RT   bromodomain family.";
RL   Cell 149:214-231(2012).
RN   [49]
RP   X-RAY CRYSTALLOGRAPHY (1.72 ANGSTROMS) OF 44-168 IN COMPLEX WITH
RP   3,5-DIMETHYLISOXAZOLE INHIBITOR.
RX   PubMed=23517011; DOI=10.1021/jm301588r;
RA   Hewings D.S., Fedorov O., Filippakopoulos P., Martin S., Picaud S.,
RA   Tumber A., Wells C., Olcina M.M., Freeman K., Gill A., Ritchie A.J.,
RA   Sheppard D.W., Russell A.J., Hammond E.M., Knapp S., Brennan P.E.,
RA   Conway S.J.;
RT   "Optimization of 3,5-dimethylisoxazole derivatives as potent bromodomain
RT   ligands.";
RL   J. Med. Chem. 56:3217-3227(2013).
RN   [50]
RP   X-RAY CRYSTALLOGRAPHY (1.43 ANGSTROMS) OF 44-167 IN COMPLEX WITH
RP   2-THIAZOLIDINONE INHIBITOR.
RX   PubMed=23530754; DOI=10.1021/jm301793a;
RA   Zhao L., Cao D., Chen T., Wang Y., Miao Z., Xu Y., Chen W., Wang X., Li Y.,
RA   Du Z., Xiong B., Li J., Xu C., Zhang N., He J., Shen J.;
RT   "Fragment-based drug discovery of 2-thiazolidinones as inhibitors of the
RT   histone reader BRD4 bromodomain.";
RL   J. Med. Chem. 56:3833-3851(2013).
RN   [51] {ECO:0007744|PDB:6BNH}
RP   STRUCTURE BY NMR OF 601-683 IN COMPLEX WITH JMJD6, INTERACTION WITH JMJD6
RP   AND NSD3, MUTAGENESIS OF 651-GLU--GLU-653, AND SUBUNIT.
RX   PubMed=29176719; DOI=10.1038/s41598-017-16588-8;
RA   Konuma T., Yu D., Zhao C., Ju Y., Sharma R., Ren C., Zhang Q., Zhou M.M.,
RA   Zeng L.;
RT   "Structural Mechanism of the Oxygenase JMJD6 Recognition by the
RT   Extraterminal (ET) Domain of BRD4.";
RL   Sci. Rep. 7:16272-16272(2017).
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=A; Synonyms=Brd4L, Long;
CC         IsoId=O60885-1; Sequence=Displayed;
CC       Name=C; Synonyms=Brd4S, Short;
CC         IsoId=O60885-2; Sequence=VSP_010902, VSP_010903;
CC       Name=B;
CC         IsoId=O60885-3; Sequence=VSP_047671;
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   CCDS; CCDS46004.1; -.
DR   RefSeq; NP_055114.1; NM_014299.2.
DR   ProteomicsDB; 49652; -.
DR   Ensembl; ENST00000371835.8; ENSP00000360901.3; ENSG00000141867.19.
DR   Proteomes; UP000005640; Chromosome 19.
PE   1: Evidence at protein level;
SQ   SEQUENCE   722 AA;  80463 MW;  FF040EE016B37F87 CRC64;
     MSAESGPGTR LRNLPVMGDG LETSQMSTTQ AQAQPQPANA ASTNPPPPET SNPNKPKRQT
     NQLQYLLRVV LKTLWKHQFA WPFQQPVDAV KLNLPDYYKI IKTPMDMGTI KKRLENNYYW
     NAQECIQDFN TMFTNCYIYN KPGDDIVLMA EALEKLFLQK INELPTEETE IMIVQAKGRG
     RGRKETGTAK PGVSTVPNTT QASTPPQTQT PQPNPPPVQA TPHPFPAVTP DLIVQTPVMT
     VVPPQPLQTP PPVPPQPQPP PAPAPQPVQS HPPIIAATPQ PVKTKKGVKR KADTTTPTTI
     DPIHEPPSLP PEPKTTKLGQ RRESSRPVKP PKKDVPDSQQ HPAPEKSSKV SEQLKCCSGI
     LKEMFAKKHA AYAWPFYKPV DVEALGLHDY CDIIKHPMDM STIKSKLEAR EYRDAQEFGA
     DVRLMFSNCY KYNPPDHEVV AMARKLQDVF EMRFAKMPDE PEEPVVAVSS PAVPPPTKVV
     APPSSSDSSS DSSSDSDSST DDSEEERAQR LAELQEQLKA VHEQLAALSQ PQQNKPKKKE
     KDKKEKKKEK HKRKEEVEEN KKSKAKEPPP KKTKKNNSSN SNVSKKEPAP MKSKPPPTYE
     SEEEDKCKPM SYEEKRQLSL DINKLPGEKL GRVVHIIQSR EPSLKNSNPD EIEIDFETLK
     PSTLRELERY VTSCLRKKRK PQAEKVDVIA GSSKMKGFSS SESESSSESS SSDSEDSETG
     PA
//
